Alvotech (ALVO) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alvotech  (NASDAQ: ALVO)


Alvotech's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alvotech's ROI in the fourth quarter of 2025?
Alvotech achieved a return on average invested assets (ROI) of 3.68 % in its fourth quarter of 2025, this is above ALVO's average return on investment of -56.29%.
Alvotech invested over the 12 months ending in its fourth quarter of 2025 $759 million

ROI has improved compared to -48.87% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 87 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 597.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 453.58 % 385.46 % 696.31 % -18.72 % -3.05 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,324 225 1,262 225 186
Return On Investment (TTM) 3.68 % -48.87 % -49.91 % -157.75 % -169.09 %
ALVO's Overall Ranking # 597 # 0 # # #
Seq. Investment Change TTM 59.99 % 2.12 % 216.09 % 7.19 % 40.3 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 28 -232 -232 -232 -232

ALVO Company Profile >> Back to ALVO Roi Comparisons >> See Annual ALVO Return On Investment



Return On Investment ALVO's Ranking
Within: No.
Industry # 18
Sector # 88
Overall # 597

Return On Investment Statistics
High Average Low
12.41 %
-56.29 %
-124.98 %
(Dec 31 2025)   (Dec 31 2024)







Financial Statements
Alvotech's IV. Quarter Investments $ 1,324 Millions ALVO's Balance sheet
Alvotech's IV. Quarter Income $ 28 Millions Quarterly ALVO's Income Statement
ALVO's Income by Division See ALVO's Income by Division


ALVO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2020)
2022
Total Investments in Millions 225 186 28 84 0
Y / Y Investment Growth 21.26 % 563.61 % -66.64 % - -
Net Income in Millions 28 -232 -552 -514 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 12.41 % -124.98 % -1973.57 % -612.94 % -


Annual Roi Comment
In the fiscal year 2025 ROI improved to 12.41 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALVO's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALVO's Competitors
Subscribers only: Roi for Alvotech's Suppliers
Subscribers only: Return On Investment for ALVO's Customers

Other Ratios
ALVO's Roa ALVO's Inventory Turnover Ratio ALVO's Growth Rates ALVO's Dividend Statistics
ALVO's Profitability Ratios ALVO's Asset Turnover Ratio ALVO's Dividend Growth
ALVO's Roe ALVO's Valuation Ratios ALVO's Financial Strength Ratios ALVO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Lemaitre Vascular Inc   10.11 %
Alnylam Pharmaceuticals Inc   10.05 %
Align Technology inc   9.70 %
Haemonetics Corporation  9.62 %
Insulet Corporation  9.55 %
Viemed Healthcare Inc   9.53 %
Galapagos Nv  9.50 %
Utah Medical Products Inc  9.49 %
National Healthcare Corp  9.28 %
Profound Medical Corp   9.18 %
Abbott Laboratories  9.09 %
Edwards Lifesciences Corporation  9.02 %
Hims and Hers Health Inc   8.93 %
Xoma Royalty Corporation  8.34 %
Boston Scientific Corporation  8.33 %
Tenet Healthcare Corp  8.33 %
Pediatrix Medical Group Inc   8.22 %
Sanofi  8.19 %
Ge Healthcare Technologies Inc   8.16 %
Kewaunee Scientific Corporation  7.98 %
Quest Diagnostics Inc  7.96 %
Infusystem Holdings Inc  7.94 %
Option Care Health Inc   7.92 %
Bio rad Laboratories Inc   7.89 %
Stryker Corp  7.73 %
Phibro Animal Health Corporation  7.64 %
Tactile Systems Technology Inc   7.64 %
Addus Homecare Corp  7.34 %
Steris Plc  7.30 %
Hologic Inc  7.26 %

Date modified: 2026-07-07T09:07:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.